Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02476968
Title To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA)
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements Yes
Sponsors AstraZeneca
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries ITA | ESP | CAN

Additional content available in CKB BOOST